Humana Stock Price, News & Analysis (NYSE:HUM)

$279.44 3.71 (1.35 %)
(As of 01/18/2018 04:00 PM ET)
Previous Close$279.44
Today's Range$275.15 - $280.00
52-Week Range$186.25 - $280.00
Volume1.31 million shs
Average Volume1.19 million shs
Market Capitalization$39.92 billion
P/E Ratio22.00
Dividend Yield0.57%
Beta0.88

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorHealthcare
SymbolNYSE:HUM
CUSIP44485910
Phone+1-502-5801000

Debt

Debt-to-Equity Ratio0.35%
Current Ratio1.61%
Quick Ratio1.61%

Price-To-Earnings

Trailing P/E Ratio22.0031496062992
Forward P/E Ratio24.03
P/E Growth1.69

Sales & Book Value

Annual Sales$54.38 billion
Price / Sales0.73
Cash Flow$13.24 per share
Price / Cash21.10
Book Value$71.66 per share
Price / Book3.90

Profitability

Trailing EPS$12.70
Net Income$614 million
Net Margins3.49%
Return on Equity15.99%
Return on Assets5.63%

Miscellaneous

Employees51,600
Outstanding Shares142,860,000

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, November 2nd. Shareholders of record on Friday, December 29th will be given a dividend of $0.40 per share on Friday, January 26th. This represents a $1.60 annualized dividend and a yield of 0.57%. The ex-dividend date of this dividend is Thursday, December 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has initiated a stock buyback plan on Friday, December 15th 2017, which authorizes the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) released its quarterly earnings data on Wednesday, November, 8th. The insurance provider reported $3.39 EPS for the quarter, beating the Zacks' consensus estimate of $3.27 by $0.12. The insurance provider earned $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company's revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.18 earnings per share. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February, 7th 2018. View Earnings Estimates for Humana.

Where is Humana's stock going? Where will Humana's stock price be in 2018?

19 brokerages have issued 1 year price objectives for Humana's stock. Their forecasts range from $210.00 to $305.00. On average, they expect Humana's stock price to reach $258.61 in the next twelve months. View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

  • 1. According to Zacks Investment Research, "Humana is well poised to grow on its strong government business. Its top line has been witnessing an uptrend for past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remains a positive. Following its strong third-quarter 2017 results, it raised its 2017  earnings  guidance. Although its shares have underperformed the industry in a year's time, its strong fundamentals are likely to help the stock gain momentum going forward. However, the company's individual commercial business has remained a drag over past few years. Rising level of expenses also continues to weigh on the bottom line. The company will release its fourth-quarter and full year 2017 results on Feb 7, 2018 before the market opens." (1/15/2018)
  • 2. Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board (Age 57)
  • Bruce D. Broussard, President, Chief Executive Officer, Director (Age 54)
  • Brian A. Kane, Chief Financial Officer, Senior Vice President (Age 44)
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President (Age 50)
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer (Age 56)
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel (Age 54)
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer (Age 59)
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer (Age 55)
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer (Age 48)

Who owns Humana stock?

Humana's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (0.73%), Schwab Charles Investment Management Inc. (0.46%), Bank of Montreal Can (0.35%), National Pension Service (0.10%), Nisa Investment Advisors LLC (0.05%) and Westpac Banking Corp (0.02%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., DnB Asset Management AS, First Citizens Bank & Trust Co., Exxonmobil Investment Management Inc. TX, Westpac Banking Corp, Contravisory Investment Management Inc., Gateway Investment Advisers LLC and Livforsakringsbolaget Skandia Omsesidigt. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Acadian Asset Management LLC, Oakbrook Investments LLC, KCS Wealth Advisory, Creative Planning, Convergence Investment Partners LLC, National Pension Service and Nisa Investment Advisors LLC. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $279.44.

How big of a company is Humana?

Humana has a market capitalization of $39.92 billion and generates $54.38 billion in revenue each year. The insurance provider earns $614 million in net income (profit) each year or $12.70 on an earnings per share basis. Humana employs 51,600 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 W Main St, LOUISVILLE, KY 40202, United States. The insurance provider can be reached via phone at +1-502-5801000.


MarketBeat Community Rating for Humana (HUM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  571 (Vote Outperform)
Underperform Votes:  665 (Vote Underperform)
Total Votes:  1,236
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Humana (NYSE:HUM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.682.582.602.63
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $258.61$255.72$253.11$231.47
Price Target Upside: 2.49% downside0.43% upside6.72% upside3.18% downside

Humana (NYSE:HUM) Consensus Price Target History

Price Target History for Humana (NYSE:HUM)

Humana (NYSE:HUM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/12/2018Jefferies GroupUpgradeHold -> Buy$221.00MediumView Rating Details
1/3/2018Goldman Sachs GroupInitiated CoverageBuy -> Buy$305.00LowView Rating Details
12/13/2017CowenReiterated RatingBuy$285.00LowView Rating Details
12/5/2017Cantor FitzgeraldReiterated RatingHold$230.00LowView Rating Details
11/10/2017Credit Suisse GroupLower Price TargetNeutral$256.00 -> $246.00N/AView Rating Details
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 -> $300.00N/AView Rating Details
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 -> $270.00N/AView Rating Details
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$245.00 -> $242.00N/AView Rating Details
10/9/2017JPMorgan Chase & Co.DowngradeOverweight -> Neutral$253.00N/AView Rating Details
8/7/2017Deutsche BankBoost Price TargetHold$234.00 -> $243.00LowView Rating Details
8/3/2017OppenheimerBoost Price TargetOutperform$236.00 -> $255.00MediumView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017CitigroupInitiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
5/30/2017Leerink SwannBoost Price TargetOutperform$250.00 -> $265.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017BarclaysReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna BancsharesReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Humana (NYSE:HUM) Earnings History and Estimates Chart

Earnings by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2018$2.02N/AView Earnings Details
11/8/2017Q3 2017$3.27$3.39$13.41 billion$13.28 billionViewN/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
11/1/2010Q3 2010$1.67$2.01ViewN/AView Earnings Details
8/2/2010Q2 2010$1.63$2.11ViewN/AView Earnings Details
4/26/2010Q1 2010$1.15$1.20ViewN/AView Earnings Details
2/1/2010Q4 2009$1.48$1.48ViewN/AView Earnings Details
11/2/2009Q3 2009$1.78$1.78ViewN/AView Earnings Details
8/3/2009Q2 2009$1.65$1.67ViewN/AView Earnings Details
4/27/2009Q1 2009$1.14$1.22ViewN/AView Earnings Details
2/2/2009Q4 2008$1.07$1.07ViewN/AView Earnings Details
10/27/2008Q3 2008$1.46$1.48ViewN/AView Earnings Details
8/4/2008Q2 2008$1.18$1.24ViewN/AView Earnings Details
4/28/2008Q1 2008$0.45$0.47ViewN/AView Earnings Details
2/4/2008Q4 2007$1.32$1.43ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Humana (NYSE:HUM) Earnings Estimates

2018 EPS Consensus Estimate: $12.12
2019 EPS Consensus Estimate: $13.75
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.64$2.86$2.75
Q2 20182$3.32$3.46$3.39
Q3 20182$3.37$3.38$3.38
Q4 20182$2.38$2.83$2.61
Q1 20191$3.29$3.29$3.29
Q2 20191$3.94$3.94$3.94
Q3 20191$3.84$3.84$3.84
Q4 20191$2.68$2.68$2.68
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Humana (NYSE:HUM) Dividend Information

Next Dividend:1/26/2018
Annual Dividend:$1.60
Dividend Yield:0.57%
Dividend Growth:10.60% (3 Year Average)
Payout Ratio:12.60% (Trailing 12 Months of Earnings)
13.76% (Based on This Year's Estimates)
12.54% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/2/2017quarterly$0.400.62%12/28/201712/29/20171/26/2018
8/17/2017$0.409/28/20179/29/201710/16/2017
8/17/2017quarterly$0.400.65%9/28/20178/29/201710/27/2017
4/20/2017quarterly$0.400.75%6/28/20176/30/20177/31/2017
2/15/2017quarterly$0.400.78%3/29/20173/31/20174/28/2017
10/26/2016quarterly$0.290.67%1/10/20171/12/20171/27/2017
8/25/2016quarterly$0.290.65%10/11/201610/13/201610/28/2016
4/21/2016quarterly$0.290.66%6/28/20166/30/20167/29/2016
2/18/2016quarterly$0.290.7%3/29/20163/31/20164/29/2016
10/29/2015quarterly$0.290.65%12/28/201512/30/20151/29/2016
8/27/2015quarterly$0.290.63%9/28/20159/30/201510/30/2015
4/17/2015quarterly$0.290.65%6/26/20156/30/20157/31/2015
2/18/2015quarterly$0.280.73%3/27/20153/31/20154/24/2015
10/31/2014quarterly$0.280.81%12/29/201412/31/20141/30/2015
8/27/2014quarterly$0.280.88%9/26/20149/30/201410/31/2014
4/30/2014quarterly$0.281.02%6/26/20146/30/20147/25/2014
2/19/2014quarterly$0.271.06%3/27/20143/31/20144/25/2014
10/30/2013quarterly$0.271.17%12/27/201312/31/20131/31/2014
8/22/2013quarterly$0.271.14%9/26/20139/30/201310/25/2013
4/25/2013quarterly$0.271.47%6/26/20136/28/20137/26/2013
2/27/2013quarterly$0.261.52%3/26/20133/28/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Humana (NYSE HUM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 94.01%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2017Brian P LeclaireSVPSell1,679$245.97$412,983.639,888View SEC Filing  
12/19/2017Timothy S HuvalVPSell1,382$246.04$340,027.2811,557View SEC Filing  
12/18/2017Jody L BilneySVPSell7,054$247.89$1,748,616.0611,704View SEC Filing  
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.0018,042View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.428,831View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.587,681View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.0080,086View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.2024,001View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.0014,258View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.008,150View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.008,978View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42171,170View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.5423,639View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.4013,578View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.6245,635View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.453,736View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.5114,258View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.5625,734View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.8776,798View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.3618,439View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88155,108View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.716,542View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.4076,798View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.6428,577View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.1317,301View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.208,730View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.801,358View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.4789,892View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.0018,225View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.0059,944View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.101,458View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.0016,226View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.007,136View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00143,339View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.6510,801View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00154,339View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.0016,473View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33111,859View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.0010,985View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.009,327View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.0021,767View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Humana (NYSE HUM) News Headlines

Source:
DateHeadline
Oppenheimer Equities Analysts Lift Earnings Estimates for Humana Inc (HUM)Oppenheimer Equities Analysts Lift Earnings Estimates for Humana Inc (HUM)
www.americanbankingnews.com - January 18 at 10:10 AM
Get to know the new CEO of the Humana FoundationGet to know the new CEO of the Humana Foundation
www.bizjournals.com - January 17 at 3:28 PM
Humana Inc (HUM) Forecasted to Post Q2 2018 Earnings of $3.46 Per ShareHumana Inc (HUM) Forecasted to Post Q2 2018 Earnings of $3.46 Per Share
www.americanbankingnews.com - January 17 at 2:04 PM
Humana Foundation Announces Focus for the Future: Addressing Social Determinants of Health for Sustainable Community ImpactHumana Foundation Announces Focus for the Future: Addressing Social Determinants of Health for Sustainable Community Impact
finance.yahoo.com - January 17 at 11:30 AM
Humana Inc (HUM) Expected to Post Quarterly Sales of $13.02 BillionHumana Inc (HUM) Expected to Post Quarterly Sales of $13.02 Billion
www.americanbankingnews.com - January 16 at 11:46 PM
Luis A. Torres Olivera Named Puerto Rico Market President for HumanaLuis A. Torres Olivera Named Puerto Rico Market President for Humana
finance.yahoo.com - January 16 at 3:27 PM
Humana (HUM) Upgraded at Zacks Investment ResearchHumana (HUM) Upgraded at Zacks Investment Research
www.americanbankingnews.com - January 15 at 8:52 AM
Reviewing Catamaran (CTRX) and Humana (HUM)Reviewing Catamaran (CTRX) and Humana (HUM)
www.americanbankingnews.com - January 14 at 7:30 PM
Humana (HUM) Upgraded at Jefferies GroupHumana (HUM) Upgraded at Jefferies Group
www.americanbankingnews.com - January 14 at 7:28 AM
Zacks: Brokerages Anticipate Humana Inc (HUM) to Announce $2.00 EPSZacks: Brokerages Anticipate Humana Inc (HUM) to Announce $2.00 EPS
www.americanbankingnews.com - January 14 at 3:30 AM
Stocks With Rising Relative Strength: HumanaStocks With Rising Relative Strength: Humana
finance.yahoo.com - January 10 at 3:28 PM
Forbes puts spotlight on Louisvilles aging-care industryForbes puts spotlight on Louisville's aging-care industry
finance.yahoo.com - January 10 at 3:28 PM
Humana Extends Contract With Tivity Health, Spurs HealthcareHumana Extends Contract With Tivity Health, Spurs Healthcare
www.zacks.com - January 10 at 9:49 AM
Humanas stock drops after downbeat PDP membership outlookHumana's stock drops after downbeat PDP membership outlook
finance.yahoo.com - January 8 at 11:02 AM
Humana Sees Relative Strength Rating Improve To 71Humana Sees Relative Strength Rating Improve To 71
finance.yahoo.com - January 5 at 3:29 PM
Humana Inc (HUM) Receives Average Recommendation of "Buy" from AnalystsHumana Inc (HUM) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 5 at 8:28 AM
4 Health Care Stocks Prescribed As Buys By Goldman Sachs4 Health Care Stocks Prescribed As Buys By Goldman Sachs
finance.yahoo.com - January 4 at 3:27 PM
Checkup: UnitedHealth, Centene Among 2018′s Health-Care WinnersCheckup: UnitedHealth, Centene Among 2018′s Health-Care Winners
finance.yahoo.com - January 3 at 3:27 PM
Humana (HUM) Now Covered by Goldman Sachs GroupHumana (HUM) Now Covered by Goldman Sachs Group
www.americanbankingnews.com - January 3 at 8:20 AM
Humana, Inc. : HUM-US: Dividend Analysis : December 29th, 2017 (record date) : By the numbers : January 1, 2018Humana, Inc. : HUM-US: Dividend Analysis : December 29th, 2017 (record date) : By the numbers : January 1, 2018
finance.yahoo.com - January 1 at 3:27 PM
Comparing Coventry Health Care (CVH) and Humana (HUM)Comparing Coventry Health Care (CVH) and Humana (HUM)
www.americanbankingnews.com - December 31 at 3:28 PM
$13.02 Billion in Sales Expected for Humana Inc (HUM) This Quarter$13.02 Billion in Sales Expected for Humana Inc (HUM) This Quarter
www.americanbankingnews.com - December 30 at 9:40 AM
 Analysts Anticipate Humana Inc (HUM) Will Post Earnings of $2.00 Per Share Analysts Anticipate Humana Inc (HUM) Will Post Earnings of $2.00 Per Share
www.americanbankingnews.com - December 28 at 8:18 AM
Big Kindred holder against Humana dealBig Kindred holder against Humana deal
seekingalpha.com - December 28 at 1:30 AM
Annual Healthcare CEOs Unscripted: A View from the Top Conference - Business Wire (press release)Annual Healthcare CEOs Unscripted: A View from the Top Conference - Business Wire (press release)
www.businesswire.com - December 27 at 6:40 PM
Brigade Capital hedge fund criticizes Humana-Kindred deal - ReutersBrigade Capital hedge fund criticizes Humana-Kindred deal - Reuters
www.reuters.com - December 27 at 1:37 PM
Humana Inc. (HUM) Ex-Dividend Date Scheduled for December 28, 2017 - NasdaqHumana Inc. (HUM) Ex-Dividend Date Scheduled for December 28, 2017 - Nasdaq
www.nasdaq.com - December 27 at 1:37 PM
Brigade Capital hedge fund criticizes Humana-Kindred dealBrigade Capital hedge fund criticizes Humana-Kindred deal
finance.yahoo.com - December 27 at 1:37 PM
Humana (HUM) Lowered to Hold at ValuEngineHumana (HUM) Lowered to Hold at ValuEngine
www.americanbankingnews.com - December 24 at 6:26 PM
Form 4 HUMANA INC For: Dec 21 Filed by: LeClaire Brian P.Form 4 HUMANA INC For: Dec 21 Filed by: LeClaire Brian P.
www.streetinsider.com - December 23 at 9:13 PM
Humana (HUM) Enters $1B Accelerated Stock Repurchase Agreement - StreetInsider.comHumana (HUM) Enters $1B Accelerated Stock Repurchase Agreement - StreetInsider.com
www.streetinsider.com - December 23 at 1:53 AM
Humana Completes Aggregate $800 Million of Senior Notes Offering - Business Wire (press release)Humana Completes Aggregate $800 Million of Senior Notes Offering - Business Wire (press release)
www.businesswire.com - December 22 at 3:52 PM
Humana Inc (HUM) SVP Brian P. Leclaire Sells 1,679 SharesHumana Inc (HUM) SVP Brian P. Leclaire Sells 1,679 Shares
www.americanbankingnews.com - December 22 at 11:30 AM
What the Kindred-Humana deal means for LouisvilleWhat the Kindred-Humana deal means for Louisville
www.bizjournals.com - December 22 at 9:16 AM
A.M. Best Comments on Humana Inc.’s Announced Joint Venture to Acquire Kindred’s Homecare BusinessA.M. Best Comments on Humana Inc.’s Announced Joint Venture to Acquire Kindred’s Homecare Business
finance.yahoo.com - December 22 at 9:16 AM
AM Best Comments on Humana Inc.s Announced Joint Venture to Acquire Kindreds Homecare Business - Business Wire (press release)AM Best Comments on Humana Inc.'s Announced Joint Venture to Acquire Kindred's Homecare Business - Business Wire (press release)
www.businesswire.com - December 21 at 3:30 PM
KINDRED INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Healthcare, Inc. - KNDKINDRED INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Healthcare, Inc. - KND
finance.yahoo.com - December 21 at 3:29 PM
Humana, Private-Equity Firms Agree to Buy Kindred HealthcareHumana, Private-Equity Firms Agree to Buy Kindred Healthcare
www.wsj.com - December 20 at 8:55 AM
Kindred Healthcare, Inc. -- Moodys places Kindreds ratings under review -- direction uncertain following announced business saleKindred Healthcare, Inc. -- Moody's places Kindred's ratings under review -- direction uncertain following announced business sale
finance.yahoo.com - December 20 at 8:55 AM
BRIEF-Kindred Healthcare to be bought by Humana, Private Equity firms - ReutersBRIEF-Kindred Healthcare to be bought by Humana, Private Equity firms - Reuters
www.reuters.com - December 19 at 3:27 PM
Humana, private equity firms buy Kindred Healthcare for $810 million - ReutersHumana, private equity firms buy Kindred Healthcare for $810 million - Reuters
www.reuters.com - December 19 at 3:27 PM
Jody L. Bilney Sells 7,054 Shares of Humana Inc (HUM) StockJody L. Bilney Sells 7,054 Shares of Humana Inc (HUM) Stock
www.americanbankingnews.com - December 19 at 2:20 PM
Timothy S. Huval Sells 1,382 Shares of Humana Inc (HUM) StockTimothy S. Huval Sells 1,382 Shares of Humana Inc (HUM) Stock
www.americanbankingnews.com - December 19 at 2:20 PM
Insurer Humana pushes into delivery of health careInsurer Humana pushes into delivery of health care
marketbeat.com - December 19 at 12:54 PM
Humana Announces Agreement to Acquire a 40 Percent Minority Interest in Kindred’s Homecare Business for Approximately $800 Million Through a Joint Venture with an Entity ...Humana Announces Agreement to Acquire a 40 Percent Minority Interest in Kindred’s Homecare Business for Approximately $800 Million Through a Joint Venture with an Entity ...
www.businesswire.com - December 19 at 9:19 AM
Kinderd Healthcare is being bought by Humana and 2 private equity firms for $4.1 billionKinderd Healthcare is being bought by Humana and 2 private equity firms for $4.1 billion
www.businessinsider.com - December 19 at 9:19 AM
Kindred Healthcare to Be Acquired by TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. for $9.00 Per Share in CashKindred Healthcare to Be Acquired by TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. for $9.00 Per Share in Cash
finance.yahoo.com - December 19 at 9:19 AM
Humana Announces Agreement to Acquire a 40 Percent Minority Interest in Kindred’s Homecare Business for Approximately $800 Million Through a Joint Venture with an Entity Owned by TPG Capital and Welsh, Carson, Anderson & StoweHumana Announces Agreement to Acquire a 40 Percent Minority Interest in Kindred’s Homecare Business for Approximately $800 Million Through a Joint Venture with an Entity Owned by TPG Capital and Welsh, Carson, Anderson & Stowe
finance.yahoo.com - December 19 at 9:19 AM
Kindred Healthcare to be bought by Humana, PE firms in $4.1 bln dealKindred Healthcare to be bought by Humana, PE firms in $4.1 bln deal
finance.yahoo.com - December 19 at 9:19 AM
Wall Streets M&A Chatter From December 15-17: Humana-Kindred Healthcare, Target-Shipt, Campbell Soup-Snyders ... - BenzingaWall Street's M&A Chatter From December 15-17: Humana-Kindred Healthcare, Target-Shipt, Campbell Soup-Snyder's ... - Benzinga
www.benzinga.com - December 18 at 3:27 PM

SEC Filings

Humana (NYSE:HUM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Humana (NYSE HUM) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.